Clinical trial
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
NCT07873463 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
- Lead sponsor
- GE Healthcare
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 22, 2026
- Completion date
- February 25, 2027
- Enrollment
- 20 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.